# Clinical Chemistry Devices; Classification of the Biotinidase Test System
> **Food and Drug Administration** · Final rule. · Published 2000-03-29 · Effective 2000-04-28 · 65 FR 16520
## Document
- **Document number:** 00-7541
- **Category:** fda-device
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 65 FR 16520
- **CFR reference:** 21 CFR 862
- **Publication date:** 2000-03-29
- **Effective date:** 2000-04-28
- **HHS docket:** Docket No. 00P-0931
## Abstract

The Food and Drug Administration (FDA) is classifying the biotinidase test system into class II (special controls). The special control that will apply to this device is restriction to sale, distribution, and use as a prescription device. The agency is taking this action in response to a petition submitted under the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Medical Device Amendments of 1976, the Safe Medical Devices Act of 1990, and the Food and Drug Administration Modernization Act of 1997. The agency is classifying these devices into class II (special controls) in order to provide a reasonable assurance of the safety and effectiveness of the devices.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2000/03/29/00-7541/clinical-chemistry-devices-classification-of-the-biotinidase-test-system)
---
*AI Analytics · CC0 1.0*